AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 34605057 — intervention group
Group type: COMPARATOR
Intervention: Connective Tissue Graft (CTG)
Number of subjects: 60
Study 34605057 — intervention group
Group type: COMPARATOR
Intervention: Control (CTG)
Number of subjects: 60
Study 32493111 — intervention group
Group type: EXPERIMENTAL
Intervention: Dorsal web space steroid injection
Number of subjects: 160
Study 32493111 — intervention group
Group type: COMPARATOR
Intervention: Palmar midline steroid injection
Number of subjects: 160
Study 35486014 — intervention group
Group type: EXPERIMENTAL
Intervention: Warming and promoting technique of acupuncture combined with extracorporeal shock wave
Number of subjects: 96
Study 35486014 — intervention group
Group type: COMPARATOR
Intervention: Even-needling technique of acupuncture combined with extracorporeal shock wave
Number of subjects: 96
Study 32867875 — intervention group
Group type: EXPERIMENTAL
Intervention: High-protein egg-based recipes and herb/spice packets
Number of subjects: 100
Study 32867875 — intervention group
Group type: COMPARATOR
Intervention: Control group (no recipes or packets)
Number of subjects: 100
Study 33663073 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified individualized RCA protocol with high‐flux dialyzer
Number of subjects: 45
Study 33663073 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified individualized RCA protocol with low‐flux dialyzer
Number of subjects: 45
Study 33663073 — intervention group
Group type: COMPARATOR
Intervention: Modified conventional RCA protocol with low‐flux dialyzer
Number of subjects: 45
Study 32682793 — intervention group
Group type: EXPERIMENTAL
Intervention: Reciproc Blue (RB) 40/.06 file in reciprocating motion
Number of subjects: 24
Study 32682793 — intervention group
Group type: EXPERIMENTAL
Intervention: ProDesign Logic (PDL) 40/.01 and 40/.05 files in rotary motion
Number of subjects: 24
Study 32682793 — intervention group
Group type: EXPERIMENTAL
Intervention: Flatsonic ultrasonic tip
Number of subjects: 24
Study 34619001 — intervention group
Group type: EXPERIMENTAL
Intervention: 20% urea cream
Number of subjects: 40
Study 34619001 — intervention group
Group type: COMPARATOR
Intervention: 10% urea cream
Number of subjects: 40
Study 32107265 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IDM intervention package (including disease targeting management, express referral channel, expert visit, patients' self-management) plus usual care
Number of subjects: 1095
Study 32107265 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 1095
Study 32107265 — intervention group
Group type: EXPERIMENTAL
Intervention: C-IDM intervention package
Number of subjects: 1095
Study 33449944 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile Stroke Units (MSU)
Number of subjects: 57
Study 33449944 — intervention group
Group type: COMPARATOR
Intervention: Standard management of tPA-eligible acute stroke patients
Number of subjects: 57
Study 32399662 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin
Number of subjects: 28
Study 32399662 — intervention group
Group type: COMPARATOR
Intervention: oGLD (intensive therapy using other glucose-lowering drugs)
Number of subjects: 28
Study 33901859 — intervention group
Group type: EXPERIMENTAL
Intervention: Exercise therapy plus manual therapy (ET plus MT)
Number of subjects: 80
Study 33901859 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy (ET)
Number of subjects: 80
Study 34035092 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical assistance in dying for patients with low socioeconomic status (SES)
Number of subjects: 50096
Study 34035092 — intervention group
Group type: COMPARATOR
Intervention: Medical assistance in dying for patients with high socioeconomic status (SES)
Number of subjects: 50096
Study 34035092 — intervention group
Group type: EXPERIMENTAL
Intervention: Odds of receiving medical assistance in dying associated with low socioeconomic status
Number of subjects: 50096
Study 32580813 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-GAA (0.6 g/kg DM)
Number of subjects: 48
Study 32580813 — intervention group
Group type: EXPERIMENTAL
Intervention: High-GAA (0.9 g/kg DM)
Number of subjects: 48
Study 32580813 — intervention group
Group type: EXPERIMENTAL
Intervention: GAA addition (0.3, 0.6, 0.9 g/kg DM)
Number of subjects: 48
Study 32580813 — intervention group
Group type: EXPERIMENTAL
Intervention: Medium-GAA (0.6 g/kg DM) and High-GAA (0.9 g/kg DM)
Number of subjects: 48
Study 35385094 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 32770262 — intervention group
Group type: EXPERIMENTAL
Intervention: Probenecid
Number of subjects: 0
Study 36323488 — intervention group
Group type: EXPERIMENTAL
Intervention: Tuberculin skin test (TST)
Number of subjects: 194
Study 36323488 — intervention group
Group type: EXPERIMENTAL
Intervention: Hepatitis B virus (HBV) monitoring
Number of subjects: 194
Study 36323488 — intervention group
Group type: EXPERIMENTAL
Intervention: Biological DMARDs treatment
Number of subjects: 194
Study 36323488 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylaxis treatment for Pneumocystis jirovecii
Number of subjects: 194
Study 32854996 — intervention group
Group type: EXPERIMENTAL
Intervention: Natural Language Processing (NLP) algorithm for detecting PJI
Number of subjects: 2396
Study 32854996 — intervention group
Group type: EXPERIMENTAL
Intervention: NLP algorithm for extracting specific PJI diagnostic elements
Number of subjects: 2396
Study 34392277 — intervention group
Group type: EXPERIMENTAL
Intervention: 3D-printed orthosis (3O)
Number of subjects: 30
Study 34392277 — intervention group
Group type: COMPARATOR
Intervention: Conventional orthosis (CO)
Number of subjects: 30
Study 33978989 — intervention group
Group type: EXPERIMENTAL
Intervention: Veteran peer telephone motivational coaching (4 sessions)
Number of subjects: 272
Study 33978989 — intervention group
Group type: EXPERIMENTAL
Intervention: Veteran peer telephone motivational coaching
Number of subjects: 272
Study 33978989 — intervention group
Group type: COMPARATOR
Intervention: Control (veteran peer-delivered MH results and referrals without motivational coaching)
Number of subjects: 272
Study 32843086 — intervention group
Group type: EXPERIMENTAL
Intervention: Third scheduled dose of human monovalent rotavirus vaccine (Rotarix)
Number of subjects: 1000
Study 35941568 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined clinical‐radiomic model
Number of subjects: 590
Study 35941568 — intervention group
Group type: COMPARATOR
Intervention: Clinical model alone
Number of subjects: 590
Study 34459213 — intervention group
Group type: EXPERIMENTAL
Intervention: Empagliflozin (10 mg once daily)
Number of subjects: 5988
Study 34459213 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5988
Study 32886932 — intervention group
Group type: EXPERIMENTAL
Intervention: 35 mg TMZ-modified release
Number of subjects: 18
Study 32886932 — intervention group
Group type: EXPERIMENTAL
Intervention: 70 mg TMZ-modified release
Number of subjects: 18
Study 32886932 — intervention group
Group type: EXPERIMENTAL
Intervention: 105 mg TMZ-modified release
Number of subjects: 18
Study 32886932 — intervention group
Group type: EXPERIMENTAL
Intervention: All doses of TMZ-modified release
Number of subjects: 18
Study 34400031 — intervention group
Group type: EXPERIMENTAL
Intervention: RME Day group (relative motion extension orthosis for day wear and an overnight wrist-hand-finger orthosis)
Number of subjects: 32
Study 34400031 — intervention group
Group type: COMPARATOR
Intervention: RME 24-Hr group (relative motion extension orthosis to be worn continuously)
Number of subjects: 32
Study 33880860 — intervention group
Group type: EXPERIMENTAL
Intervention: Platelet-rich plasma (PRP) treatment, intradermal and subdermal injection weekly for 4-6 sessions.
Number of subjects: 80
Study 33880860 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment (compression and dressing) for chronic venous leg ulcers.
Number of subjects: 80
Study 33292924 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic capsular release
Number of subjects: 503
Study 33292924 — intervention group
Group type: EXPERIMENTAL
Intervention: Manipulation under anaesthesia
Number of subjects: 503
Study 33292924 — intervention group
Group type: EXPERIMENTAL
Intervention: Early structured physiotherapy with a steroid injection
Number of subjects: 503
Study 36307642 — intervention group
Group type: EXPERIMENTAL
Intervention: FHH platform (immediate arm)
Number of subjects: 505
Study 36307642 — intervention group
Group type: COMPARATOR
Intervention: Electronic medical record (EMR) (control arm)
Number of subjects: 505
Study 36307642 — intervention group
Group type: EXPERIMENTAL
Intervention: PCP risk‐concordant action (both arms)
Number of subjects: 505
Study 36307642 — intervention group
Group type: EXPERIMENTAL
Intervention: Risk‐concordant screening test completion (both arms)
Number of subjects: 505
Study 36307642 — intervention group
Group type: EXPERIMENTAL
Intervention: Recommendation for genetic consultation (immediate arm)
Number of subjects: 505
Study 36307642 — intervention group
Group type: COMPARATOR
Intervention: Recommendation for genetic consultation (control arm)
Number of subjects: 505
Study 36307642 — intervention group
Group type: EXPERIMENTAL
Intervention: Referral for genetic consultation (both arms)
Number of subjects: 505
Study 32909326 — intervention group
Group type: EXPERIMENTAL
Intervention: Sour tea supplementation (450 mg capsule daily for 8 weeks)
Number of subjects: 70
Study 32909326 — intervention group
Group type: COMPARATOR
Intervention: Placebo (capsule daily for 8 weeks)
Number of subjects: 70
Study 32029409 — intervention group
Group type: COMPARATOR
Intervention: SL-PLUS™
Number of subjects: 80
Study 32029409 — intervention group
Group type: EXPERIMENTAL
Intervention: SL-PLUS MIA™
Number of subjects: 80
Study 34303591 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial primary closure (PPC) technique applied to 46 patients
Number of subjects: 96
Study 34303591 — intervention group
Group type: COMPARATOR
Intervention: Karydakis flap (KF) technique applied to 50 patients
Number of subjects: 96
Study 34303591 — intervention group
Group type: EXPERIMENTAL
Intervention: Partial primary closure (PPC) technique
Number of subjects: 96
Study 34303591 — intervention group
Group type: COMPARATOR
Intervention: Karydakis flap (KF) technique
Number of subjects: 96
Study 33684370 — intervention group
Group type: EXPERIMENTAL
Intervention: TPEx regimen (docetaxel 75 mg/m2, cisplatin 75 mg/m2, cetuximab 400 mg/m2 on day 1 of cycle 1 and 250 mg/m2 weekly thereafter)
Number of subjects: 541
Study 33684370 — intervention group
Group type: COMPARATOR
Intervention: EXTREME regimen (fluorouracil 4000 mg/m2 on days 1-4, cisplatin 100 mg/m2 on day 1, cetuximab 400 mg/m2 on day 1 of cycle 1 and 250 mg/m2 weekly thereafter)
Number of subjects: 541
Study 33684370 — intervention group
Group type: EXPERIMENTAL
Intervention: TPEx regimen
Number of subjects: 541
Study 33684370 — intervention group
Group type: COMPARATOR
Intervention: EXTREME regimen
Number of subjects: 541
Study 34098026 — intervention group
Group type: EXPERIMENTAL
Intervention: Joyful music
Number of subjects: 27
Study 34098026 — intervention group
Group type: EXPERIMENTAL
Intervention: Fearful music
Number of subjects: 27
Study 34098026 — intervention group
Group type: COMPARATOR
Intervention: No music
Number of subjects: 27
Study 35655124 — intervention group
Group type: EXPERIMENTAL
Intervention: Purple grape juice supplementation
Number of subjects: 47
Study 35655124 — intervention group
Group type: COMPARATOR
Intervention: Control drink
Number of subjects: 47
Study 32083490 — intervention group
Group type: EXPERIMENTAL
Intervention: LBPT tablet
Number of subjects: 0
Study 35837972 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh in the retromuscular position around the stoma site
Number of subjects: 232
Study 35837972 — intervention group
Group type: COMPARATOR
Intervention: No mesh
Number of subjects: 232
Study 35837972 — intervention group
Group type: EXPERIMENTAL
Intervention: Prophylactic mesh
Number of subjects: 232
Study 33683433 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality exposure prior to surgery
Number of subjects: 126
Study 33683433 — intervention group
Group type: COMPARATOR
Intervention: No virtual reality exposure (control group)
Number of subjects: 126
Study 32103423 — intervention group
Group type: EXPERIMENTAL
Intervention: Refutation text
Number of subjects: 97
Study 32103423 — intervention group
Group type: COMPARATOR
Intervention: Dyslexia Basics text
Number of subjects: 97
Study 32103423 — intervention group
Group type: EXPERIMENTAL
Intervention: Delayed posttest (both groups)
Number of subjects: 97
Study 34932434 — intervention group
Group type: EXPERIMENTAL
Intervention: Water exchange colonoscopy (WEC)
Number of subjects: 104
Study 34932434 — intervention group
Group type: COMPARATOR
Intervention: Air insufflation colonoscopy (AIC)
Number of subjects: 104
Study 33761061 — intervention group
Group type: EXPERIMENTAL
Intervention: Music group
Number of subjects: 52
Study 33761061 — intervention group
Group type: COMPARATOR
Intervention: Non-music group (Control)
Number of subjects: 52
Study 32952087 — intervention group
Group type: EXPERIMENTAL
Intervention: Pharmacy staff self-reported scores
Number of subjects: 270
Study 32952087 — intervention group
Group type: EXPERIMENTAL
Intervention: Simulated patient (SP) scores
Number of subjects: 270
Study 36434698 — intervention group
Group type: EXPERIMENTAL
Intervention: Cooking Matters for Parents
Number of subjects: 51
Study 36434698 — intervention group
Group type: EXPERIMENTAL
Intervention: Mealtime PREP
Number of subjects: 51
Study 36434698 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined program (Cooking Matters + Mealtime PREP)
Number of subjects: 51
Study 34020245 — intervention group
Group type: EXPERIMENTAL
Intervention: eHealthResp online course
Number of subjects: 19
Study 32865944 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose topical creatine cream (3.5 ml)
Number of subjects: 123
Study 32865944 — intervention group
Group type: EXPERIMENTAL
Intervention: High-dose topical creatine cream (7 ml)
Number of subjects: 123
Study 32865944 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical creatine cream after 7-day supplementation
Number of subjects: 123
Study 32865944 — intervention group
Group type: COMPARATOR
Intervention: Placebo cream after 7-day supplementation
Number of subjects: 123
Study 36274471 — intervention group
Group type: EXPERIMENTAL
Intervention: Beginning Movement Load Training (BMLT)
Number of subjects: 20
Study 36274471 — intervention group
Group type: COMPARATOR
Intervention: Conventional leg press training
Number of subjects: 20
Study 33864070 — intervention group
Group type: EXPERIMENTAL
Intervention: Insufficient 25(OH)D (<30 ng/ml)
Number of subjects: 1267
Study 33864070 — intervention group
Group type: COMPARATOR
Intervention: iPTH, Ca, FGF23, and 1,25(OH)2D
Number of subjects: 1267
Study 32553497 — intervention group
Group type: EXPERIMENTAL
Intervention: Voiced High-Frequency Oscillation (VHFO)
Number of subjects: 30
Study 32553497 — intervention group
Group type: EXPERIMENTAL
Intervention: Lax Vox technique
Number of subjects: 30
Study 32484870 — intervention group
Group type: EXPERIMENTAL
Intervention: Battery of five ADS screening instruments
Number of subjects: 2637
Study 32484870 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-item self-report question about having ADS
Number of subjects: 2637
Study 32484870 — intervention group
Group type: EXPERIMENTAL
Intervention: Single-item self-report question with added interference belief question
Number of subjects: 2637
Study 32484870 — intervention group
Group type: COMPARATOR
Intervention: Battery of screening instruments
Number of subjects: 2637
Study 35599920 — intervention group
Group type: EXPERIMENTAL
Intervention: Caffeinated MIPS (C)
Number of subjects: 24
Study 35599920 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-caffeinated MIPS (NC)
Number of subjects: 24
Study 35599920 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 24
Study 34167567 — intervention group
Group type: EXPERIMENTAL
Intervention: Basiliximab induction therapy
Number of subjects: 0
Study 33290853 — intervention group
Group type: EXPERIMENTAL
Intervention: Liposomal bupivacaine
Number of subjects: 0
Study 33290853 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 0
Study 32479321 — intervention group
Group type: EXPERIMENTAL
Intervention: Esketamine nasal spray + newly initiated oral antidepressant (esketamine+AD)
Number of subjects: 0
Study 33388426 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI) combined with 5-fluorouracil (5-FU)
Number of subjects: 0
Study 33388426 — intervention group
Group type: EXPERIMENTAL
Intervention: Shenmai injection (SMI) combined with neoadjuvant chemotherapy
Number of subjects: 0
Study 33388426 — intervention group
Group type: COMPARATOR
Intervention: Control group (neoadjuvant chemotherapy without SMI)
Number of subjects: 0
Study 32389610 — intervention group
Group type: EXPERIMENTAL
Intervention: Physical Activity (PA) guidelines for older adults with SCD/MCI
Number of subjects: 22
Study 32389610 — intervention group
Group type: COMPARATOR
Intervention: Canadian Physical Activity Guidelines for Older Adults
Number of subjects: 22
Study 33896815 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercises with core stabilization exercises (BSET)
Number of subjects: 43
Study 33896815 — intervention group
Group type: COMPARATOR
Intervention: Stabilization exercises (SET)
Number of subjects: 43
Study 35581440 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab (32 monthly doses, titrated up to 6 mg/kg, cumulative dose of 186 mg/kg)
Number of subjects: 1
Study 35581440 — intervention group
Group type: EXPERIMENTAL
Intervention: Aducanumab
Number of subjects: 1
Study 32414817 — intervention group
Group type: EXPERIMENTAL
Intervention: Learning Together intervention
Number of subjects: 0
Study 34523872 — intervention group
Group type: EXPERIMENTAL
Intervention: Subcutaneous specific immunotherapy (SSI) with whole body bed bug extract
Number of subjects: 20
Study 34523872 — intervention group
Group type: COMPARATOR
Intervention: Conventional treatment
Number of subjects: 20
Study 32014035 — intervention group
Group type: EXPERIMENTAL
Intervention: Fecal microbiota transplantation (FMT)
Number of subjects: 17
Study 32014035 — intervention group
Group type: COMPARATOR
Intervention: Sham transplantation
Number of subjects: 17
Study 36434148 — intervention group
Group type: EXPERIMENTAL
Intervention: Mentalization-based treatment for adolescents with CD (MBT-CD)
Number of subjects: 45
Study 33071262 — intervention group
Group type: EXPERIMENTAL
Intervention: Active learning education program (90-minute sessions for 24 weeks)
Number of subjects: 60
Study 33071262 — intervention group
Group type: COMPARATOR
Intervention: Control group (90-minute health education class in a didactic manner)
Number of subjects: 60
Study 32730174 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity IMST (75% maximal inspiratory pressure)
Number of subjects: 25
Study 32730174 — intervention group
Group type: COMPARATOR
Intervention: Control intervention (15% maximum inspiratory pressure)
Number of subjects: 25
Study 35854800 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound-guided quadratus lumborum block (QLB)
Number of subjects: 50
Study 35854800 — intervention group
Group type: COMPARATOR
Intervention: Lumbar plexus block (LPB)
Number of subjects: 50
Study 32858033 — intervention group
Group type: EXPERIMENTAL
Intervention: NSAIDs
Number of subjects: 72
Study 32858033 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 72
Study 32416981 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotic group (received acetaminophen, ibuprofen, and narcotic)
Number of subjects: 126
Study 32416981 — intervention group
Group type: COMPARATOR
Intervention: Nonnarcotic group (received acetaminophen and ibuprofen)
Number of subjects: 126
Study 32416981 — intervention group
Group type: EXPERIMENTAL
Intervention: Narcotic group
Number of subjects: 126
Study 32416981 — intervention group
Group type: COMPARATOR
Intervention: Nonnarcotic group
Number of subjects: 126
Study 32347143 — intervention group
Group type: EXPERIMENTAL
Intervention: HIV self-testing (HIVST)
Number of subjects: 297
Study 33722312 — intervention group
Group type: EXPERIMENTAL
Intervention: Ca-specific intervention targeted towards parents
Number of subjects: 239
Study 33722312 — intervention group
Group type: COMPARATOR
Intervention: Generic dietary advice
Number of subjects: 239
Study 34975069 — intervention group
Group type: EXPERIMENTAL
Intervention: Scheduled phosphodiesterase 5 inhibitor (PDE5i) 5 mg tadalafil once a day (OaD) combined with vacuum erectile device (VED)
Number of subjects: 100
Study 34975069 — intervention group
Group type: EXPERIMENTAL
Intervention: Vacuum erectile device (VED) alone
Number of subjects: 100
Study 34975069 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination therapy of VED and tadalafil OaD
Number of subjects: 100
Study 34975069 — intervention group
Group type: COMPARATOR
Intervention: Control group without any intervention
Number of subjects: 100
Study 34392138 — intervention group
Group type: EXPERIMENTAL
Intervention: Adherence monitoring with audiovisual medication reminders
Number of subjects: 85
Study 34392138 — intervention group
Group type: COMPARATOR
Intervention: Adherence monitoring only
Number of subjects: 85
Study 32201990 — intervention group
Group type: EXPERIMENTAL
Intervention: Virtual reality game of Snakes
Number of subjects: 18
Study 32201990 — intervention group
Group type: COMPARATOR
Intervention: Anaglyph intervention
Number of subjects: 18
Study 32201990 — intervention group
Group type: EXPERIMENTAL
Intervention: Both interventions
Number of subjects: 18
Study 36175995 — intervention group
Group type: EXPERIMENTAL
Intervention: Maternal fecal microbiota (FMT) administered orally in breast milk during the first feeding
Number of subjects: 60
Study 36175995 — intervention group
Group type: COMPARATOR
Intervention: Placebo treatment administered orally in breast milk during the first feeding
Number of subjects: 60
Study 34192430 — intervention group
Group type: EXPERIMENTAL
Intervention: 10 mg ZED1227
Number of subjects: 162
Study 34192430 — intervention group
Group type: EXPERIMENTAL
Intervention: 50 mg ZED1227
Number of subjects: 162
Study 34192430 — intervention group
Group type: EXPERIMENTAL
Intervention: 100 mg ZED1227
Number of subjects: 162
Study 34192430 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 162
Study 32466070 — intervention group
Group type: COMPARATOR
Intervention: Standard Release Tacrolimus (SRT)
Number of subjects: 70
Study 32466070 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Release Tacrolimus (PRT)
Number of subjects: 70
Study 35226523 — intervention group
Group type: EXPERIMENTAL
Intervention: Tirzepatide
Number of subjects: 0
Study 35226523 — intervention group
Group type: COMPARATOR
Intervention: Insulin glargine
Number of subjects: 0
Study 34919838 — intervention group
Group type: EXPERIMENTAL
Intervention: Pragmatic trial interventions
Number of subjects: 0
Study 34919838 — intervention group
Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0